There are no symptoms of Ovarian Cancer, and even worse there is no test to find it early. But now, researchers at UT Southwestern Medical Center in Dallas say they are developing a simple blood test that measures a specific cancer-driven protein which is finding that cancer earlier.
"We identified one of these proteins that was overproduced 184 times compared to normal, and then we thought, 'I wonder if that's measurable in the blood?' and so we tested it in the blood, it's called Osteopontin," said John Schorge, M.D., an OB-GYN at UT Southwestern.
Researchers are hoping that in as little as five years, women could have this simple blood test during their annual check up to detect Ovarian Cancer. The cure rate for early stage Ovarian Ccancer is 95%.
Drugs designed to trigger a patient's immune system may help boost survival for those battling lung cancer, two new studies found.
Women who survive a heart attack are less likely than men to receive cholesterol-lowering statin drugs that can reduce the risk of another heart attack or stroke, a new study finds.